From April 1, 2022 to June 30, 2022, the company has repurchased 1,470,456 shares, representing 1.26% for $200 million. With this, the company has completed the repurchase of 85,243,240 shares, representing 58.99% for $7,357.56 million under the buyback announced on October 20, 2010.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,734 GBX | +0.29% | +4.87% | +19.54% |
05-03 | GSK : DZ Bank remains Neutral | ZD |
05-03 | GSK plc : Back on track |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.54% | 88.72B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.